The lucrative and unregulated market of semi-synthetic cannabinoids is rapidly expanding across Europe, raising public health concerns and posing a legislative challenge to policymakers. The solution lies not in prohibition but in regulation.
New Psychoactive Substances
What Are Nitazines? Interview with Shayla Schlossenberg at the UN
You have likely heard of a new group of synthetic substances, Nitazines, increasingly sold on illicit drug markets in North America and in Europe. We interviewed Shayla Schlossenberg, Drug Service Coordinator at Release, a UK-based drug policy and human rights NGO.
The New EU Drug Agency Seeks Stronger Partnership with Civil Society
The EU’s drug monitoring agency organised a meeting with civil society in Lisbon to discuss future cooperation outlined in its new mandate. Read this short report about the meeting by Marie Nougier (IDPC) and Peter Sarosi!
Abandonded – Designer Drugs on the Margins of Hungarian Society
How does the use of new psychoactive substances, such as “herbal” or “crystal”, affect the Hungarian countryside and cities in 2024? How does Hungarian society treat the users of these drugs? Drug users, ex-dealers, the mayor, helpers and experts answer these questions in a new documentary by Drugreporter.
Harm Reduction Unmuted
More than 400 professionals and community activists gathered in Prague to attend the 5th European Harm Reduction Conference. Watch and share Drugreporter’s video report!
Boosters – (Not so) New Drugs in Poland
The members of Drugreporter’s video advocacy network produced a movie about the new generation of synthetic drugs that conquered Poland in 2008 – and are still popular.
The problem of alpha-PVP in Russia and other post-Soviet states
On Russian YouTube, there are videos of alpha-PVP users, acting in bizarre and uncontrollable ways. It’s just one small sign of a vast, hidden epidemic. Read this report from Sam Iravani!
A Reality Check of the Official Data on Harm Reduction – Interview with Eberhard Schatz
The Correlation European Harm Reduction Network published its first monitoring report (download here!) of harm reduction in Europe. On this occasion, we interviewed Eberhard Schatz, one of the two coordinators of the network about new trends and challenges.
The Unchallenged Rule of the Designer Drugs in Hungary
Although the drug strategy adopted by the Hungarian government in 2013 aimed to make the country drug-free by 2020, the (not so) new synthetic drugs still rule the country. After the municipal elections, there is some hope that harm reduction can return to Budapest.
What Works on the Ground in Europe? – 4 Case Studies
In this report we present four best practices in the field of drug demand and harm reduction from three countries. With this report, we would like to promote the culture of evaluation both among civil society organisations and decision makers.
